Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients

The aim of this study was to evaluate the role of WT1 expression after allogeneic stem cell transplantation (alloHSCT) in patients with acute myeloid leukemia (AML). We studied WT1 expression in bone marrow cells from 50 patients in complete remission on day +60 after transplant. WT1 was assessed on...

Descripció completa

Dades bibliogràfiques

Autors principals:	Patrizia Chiusolo, Elisabetta Metafuni, Gessica Minnella, Sabrina Giammarco, Silvia Bellesi, Monica Rossi, Federica Sorà, Maria Assunta Limongiello, Filippo Frioni, Nicola Piccirillo, Maria Bianchi, Caterina Giovanna Valentini, Luciana Teofili, Simona Sica, Andrea Bacigalupo
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-08-01
Col·lecció:	Frontiers in Oncology
Matèries:	AML stem cell transplantation minimal residual disease stem cell transplant (SCT) minimal residual disease (MRD) WT1
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2022.994366/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!